© 1998 by Oxford University Press
Journal Of The National Cancer Institute, Vol 90, 1219-1224, Copyright © 1998 by Oxford University Press
K Yoshizawa, WC Willett, SJ Morris, MJ Stampfer, D Spiegelman, EB Rimm and E Giovannucci
BACKGROUND: In a recent randomized intervention trial, the risk of prostate
cancer for men receiving a daily supplement of 200 microg selenium was one
third of that for men receiving placebo. By use of a nested case-control
design within a prospective study, i.e., the Health Professionals Follow-Up
Study, we investigated the association between risk of prostate cancer and
prediagnostic level of selenium in toenails, a measure of long-term
selenium intake. METHODS: In 1986, 51,529 male health professionals aged
40-75 years responded to a mailed questionnaire to form the prospective
study. In 1987, 33,737 cohort members provided toenail clippings. In 1988,
1990, 1992, and 1994, follow-up questionnaires were mailed. From 1989
through 1994, 181 new cases of advanced prostate cancer were reported. Case
and control subjects were matched by age, smoking status, and month of
toenail return. Selenium levels were determined by neutron activation. All
P values are two-sided. RESULTS: The selenium level in toenails varied
substantially among men, with quintile medians ranging from 0.66 to 1.14
microg/g for control subjects. When matched case-control data were
analyzed, higher selenium levels were associated with a reduced risk of
advanced prostate cancer (odds ratio [OR] for comparison of highest to
lowest quintile = 0.49; 95% confidence interval [CI] = 0.25-0.96; P for
trend = .11). After additionally controlling for family history of prostate
cancer, body mass index, calcium intake, lycopene intake, saturated fat
intake, vasectomy, and geographical region, the OR was 0.35 (95% CI =
0.16-0.78; P for trend = .03). CONCLUSIONS: Our results support earlier
findings that higher selenium intakes may reduce the risk of prostate
cancer. Further prospective studies and randomized trials of this
relationship should be conducted.
ARTICLES
Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Chan, W. K. Oh, W. Xie, M. M. Regan, M. J. Stampfer, I. B. King, M. Abe, and P. W. Kantoff Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer J. Clin. Oncol., August 1, 2009; 27(22): 3577 - 3583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Platz and S. M. Lippman Selenium, Genetic Variation, and Prostate Cancer Risk: Epidemiology Reflects Back on Selenium and Vitamin E Cancer Prevention Trial J. Clin. Oncol., August 1, 2009; 27(22): 3569 - 3572. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Venkateswaran, L. H. Klotz, M. Ramani, L. M. Sugar, L. E. Jacob, R. K. Nam, and N. E. Fleshner A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model Cancer Prevention Research, May 1, 2009; 2(5): 473 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tsavachidou, T. J. McDonnell, S. Wen, X. Wang, F. Vakar-Lopez, L. L. Pisters, C. A. Pettaway, C. G. Wood, K.-A. Do, P. F. Thall, et al. Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer J Natl Cancer Inst, March 4, 2009; 101(5): 306 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman, E. A. Klein, P. J. Goodman, M. S. Lucia, I. M. Thompson, L. G. Ford, H. L. Parnes, L. M. Minasian, J. M. Gaziano, J. A. Hartline, et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA, January 7, 2009; 301(1): 39 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Cooper, H.-O. Adami, H. Gronberg, F. Wiklund, F. R. Green, and M. P. Rayman Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk Cancer Res., December 15, 2008; 68(24): 10171 - 10177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E Allen, P. N Appleby, A. W Roddam, A. Tjonneland, N. F. Johnsen, K. Overvad, H. Boeing, S. Weikert, R. Kaaks, J. Linseisen, et al. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1567 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Adams A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium Bioscience Horizons, March 1, 2008; 1(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bardia, I. M. Tleyjeh, J. R. Cerhan, A. K. Sood, P. J. Limburg, P. J. Erwin, and V. M. Montori Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis Mayo Clin. Proc., January 1, 2008; 83(1): 23 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Syed, N. Khan, F. Afaq, and H. Mukhtar Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2193 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Chun, Y. Hu, E. Pinder, J. Wu, F. Li, and A. C. Gao Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter Mol. Cancer Ther., September 1, 2007; 6(9): 2572 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes Serum selenium and risk of prostate cancer--a nested case-control study Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al. Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Diwadkar-Navsariwala, G. S. Prins, S. M. Swanson, L. A. Birch, V. H. Ray, S. Hedayat, D. L. Lantvit, and A. M. Diamond Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model PNAS, May 23, 2006; 103(21): 8179 - 8184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Chun, N. Nadiminty, S. O. Lee, S. A. Onate, W. Lou, and A. C. Gao Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer. Mol. Cancer Ther., April 1, 2006; 5(4): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Sabichi, J. J. Lee, R. J. Taylor, I. M. Thompson, B. J. Miles, C. M. Tangen, L. M. Minasian, L. L. Pisters, J. R. Caton, J. W. Basler, et al. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2178 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhao, N. Xiang, F. E. Domann, and W. Zhong Expression of p53 Enhances Selenite-Induced Superoxide Production and Apoptosis in Human Prostate Cancer Cells Cancer Res., February 15, 2006; 66(4): 2296 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hu, R. V. Benya, R. E. Carroll, and A. M. Diamond Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer J. Nutr., December 1, 2005; 135(12): 3021S - 3024S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Chan, P. H. Gann, and E. L. Giovannucci Role of Diet in Prostate Cancer Development and Progression J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. T. Akbaraly, J. Arnaud, I. Hininger-Favier, V. Gourlet, A.-M. Roussel, and C. Berr Selenium and Mortality in the Elderly: Results from the EVA Study Clin. Chem., November 1, 2005; 51(11): 2117 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajpathak, E. Rimm, J. S. Morris, and F. Hu Toenail Selenium and Cardiovascular Disease in Men with Diabetes J. Am. Coll. Nutr., August 1, 2005; 24(4): 250 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Waters, S. Shen, L. T. Glickman, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr, and J. S. Morris Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model Carcinogenesis, July 1, 2005; 26(7): 1256 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. FINLEY Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds Ann. Bot., June 1, 2005; 95(7): 1075 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, P. W. Kantoff, E. Giovannucci, M. F. Leitzmann, J. M. Gaziano, M. J. Stampfer, and J. Ma Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer Cancer Res., March 15, 2005; 65(6): 2498 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Taylor and P. Greenwald Nutritional Interventions in Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Diwadkar-Navsariwala and A. M. Diamond The Link between Selenium and Chemoprevention: A Case for Selenoproteins J. Nutr., November 1, 2004; 134(11): 2899 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Dangour, V. L. Sibson, and A. E. Fletcher Hormones and Supplements: Do They Work?: Micronutrient Supplementation in Later Life: Limited Evidence for Benefit J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B659 - B673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Homma, Y. Kondo, M. Kaneko, T. Kitamura, W. T. Nyou, M. Yanagisawa, Y. Yamamoto, and T. Kakizoe Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate Carcinogenesis, June 1, 2004; 25(6): 1011 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Taylor, H. L. Parnes, and S. M. Lippman Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647. [Full Text] [PDF]
|
|
|
|
|
|
H. Li, M. J. Stampfer, E. L. Giovannucci, J. S. Morris, W. C. Willett, J. M. Gaziano, and J. Ma A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk J Natl Cancer Inst, May 5, 2004; 96(9): 696 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Karunasinghe, J. Ryan, J. Tuckey, J. Masters, M. Jamieson, L. C. Clarke, J. R. Marshall, and L. R. Ferguson DNA Stability and Serum Selenium Levels in a High-Risk Group for Prostate Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 391 - 397. [Abstract] [Full Text]
|
|
|
|
|
|
K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells Mol. Biol. Cell, February 1, 2004; 15(2): 506 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yoshizawa, A. Ascherio, J. S. Morris, M. J. Stampfer, E. Giovannucci, C. K. Baskett, W. C. Willett, and E. B. Rimm Prospective Study of Selenium Levels in Toenails and Risk of Coronary Heart Disease in Men Am. J. Epidemiol., November 1, 2003; 158(9): 852 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Irmak, G. Ince, M. Ozturk, and R. Cetin-Atalay Acquired Tolerance of Hepatocellular Carcinoma Cells to Selenium Deficiency: A Selective Survival Mechanism? Cancer Res., October 15, 2003; 63(20): 6707 - 6715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Saito, Y. Yoshida, T. Akazawa, K. Takahashi, and E. Niki Cell Death Caused by Selenium Deficiency and Protective Effect of Antioxidants J. Biol. Chem., October 10, 2003; 278(41): 39428 - 39434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. van den Brandt, M. P. A. Zeegers, P. Bode, and R. A. Goldbohm Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer: A Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 866 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Hu and A. M. Diamond Role of Glutathione Peroxidase 1 in Breast Cancer: Loss of Heterozygosity and Allelic Differences in the Response to Selenium Cancer Res., June 15, 2003; 63(12): 3347 - 3351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Marshall Methodologic and Statistical Considerations Regarding Use of Biomarkers of Nutritional Exposure in Epidemiology J. Nutr., March 1, 2003; 133(3): 881S - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr., L. T. Glickman, C. Oteham, D. Schlittler, and J. S. Morris Effects of Dietary Selenium Supplementation on DNA Damage and Apoptosis in Canine Prostate J Natl Cancer Inst, February 5, 2003; 95(3): 237 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Pak, V. J. Lanteri, J. R. Scheuch, and I. S. Sawczuk Review of Vitamin E and Selenium in the Prevention of Prostate Cancer: Implications of the Selenium and Vitamin E Chemoprevention Trial Integr Cancer Ther, December 1, 2002; 1(4): 338 - 344. [Abstract] [PDF]
|
|
|
|
|
|
P. Greenwald Cancer Prevention Clinical Trials J. Clin. Oncol., September 15, 2002; 20(90001): 14s - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cox, M. J. Sneyd, C. Paul, B. Delahunt, and D. C. G. Skegg Vasectomy and Risk of Prostate Cancer JAMA, June 19, 2002; 287(23): 3110 - 3115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Venkateswaran, L. H. Klotz, and N. E. Fleshner Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines Cancer Res., May 1, 2002; 62(9): 2540 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Simopoulos The Mediterranean Diets: What Is So Special about the Diet of Greece? The Scientific Evidence J. Nutr., November 1, 2001; 131(11): 3065S - 3073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Goodman, S. Schaffer, D. D. Bankson, M. P. Hughes, and G. S. Omenn Predictors of Serum Selenium in Cigarette Smokers and the Lack of Association with Lung and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1069 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhong and T. D. Oberley Redox-mediated Effects of Selenium on Apoptosis and Cell Cycle in the LNCaP Human Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(19): 7071 - 7078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brown, T. Byers, K. Thompson, B. Eldridge, C. Doyle, A. M. Williams, and American Cancer Society Workgroup on Nutrition and Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors CA Cancer J Clin, May 1, 2001; 51(3): 153 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jun Hu, K. V. Korotkov, R. Mehta, D. L. Hatfield, C. N. Rotimi, A. Luke, T. E. Prewitt, R. S. Cooper, W. Stock, E. E. Vokes, et al. Distribution and Functional Consequences of Nucleotide Polymorphisms in the 3'-Untranslated Region of the Human Sep15 Gene Cancer Res., March 1, 2001; 61(5): 2307 - 2310. [Abstract] [Full Text]
|
|
|
|
|
|
E. Giovannucci {{gamma}}-Tocopherol: a New Player in Prostate Cancer Prevention? J Natl Cancer Inst, December 20, 2000; 92(24): 1966 - 1967. [Full Text] [PDF]
|
|
|
|
|
|
K. J. Helzlsouer, H.-Y. Huang, A. J. Alberg, S. Hoffman, A. Burke, E. P. Norkus, J. S. Morris, and G. W. Comstock Association Between {{alpha}}-Tocopherol, {{gamma}}-Tocopherol, Selenium, and Subsequent Prostate Cancer J Natl Cancer Inst, December 20, 2000; 92(24): 2018 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Menter, A. L. Sabichi, and S. M. Lippman Selenium Effects on Prostate Cell Growth Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1171 - 1182. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Y. Nomura, J. Lee, G. N. Stemmermann, and G. F. Combs Jr. Serum Selenium and Subsequent Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 883 - 887. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Chan, M. J. Stampfer, J. Ma, E. B. Rimm, W. C. Willett, and E. L. Giovannucci Supplemental Vitamin E Intake and Prostate Cancer Risk in a Large Cohort of Men in the United States Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 893 - 899. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Gasdaska, J. W. Harney, P. Y. Gasdaska, G. Powis, and M. J. Berry Regulation of Human Thioredoxin Reductase Expression and Activity by 3'-Untranslated Region Selenocysteine Insertion Sequence and mRNA Instability Elements J. Biol. Chem., September 3, 1999; 274(36): 25379 - 25385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Gann, J. Ma, E. Giovannucci, W. Willett, F. M. Sacks, C. H. Hennekens, and M. J. Stampfer Lower Prostate Cancer Risk in Men with Elevated Plasma Lycopene Levels: Results of a Prospective Analysis Cancer Res., March 1, 1999; 59(6): 1225 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kumaraswamy, A. Malykh, K. V. Korotkov, S. Kozyavkin, Y. Hu, S. Y. Kwon, M. E. Moustafa, B. A. Carlson, M. J. Berry, B. J. Lee, et al. Structure-Expression Relationships of the 15-kDa Selenoprotein Gene. POSSIBLE ROLE OF THE PROTEIN IN CANCER ETIOLOGY J. Biol. Chem., November 3, 2000; 275(45): 35540 - 35547. [Abstract] [Full Text] [PDF]
|
|